JENNIFER KNIP: Open Payments
NPI 1669956272 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,941 in 111 payments from 17 companies in 2025. Trend: 2023 $3,096 · 2024 $2,779 · 2025 $1,941
Food & beverage: $1,741Education: $200
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $465 |
| Amgen Inc. | 25 | $448 |
| Janssen Biotech, Inc. | 9 | $296 |
| AstraZeneca Pharmaceuticals LP | 5 | $125 |
| Novartis Pharmaceuticals Corporation | 4 | $114 |
| UCB, Inc. | 5 | $102 |
| PFIZER INC. | 5 | $88 |
| Actelion Pharmaceuticals US, Inc. | 2 | $60 |
| Lilly USA, LLC | 2 | $55 |
| SOBI, INC | 2 | $46 |
Products named: RINVOQ, TREMFYA, EVENITY, SAPHNELO, ENBREL, Bimzelx, XELJANZ, SKYRIZI.
Industry payments across MI — which companies pay providers there.
